The limitations of liver biopsy (invasive procedure, sampling errors, inter‐observer variability
and nondynamic fibrosis evaluation) have stimulated the search for noninvasive approaches …

Background The hepatitis C virus (HCV) is a major public health problem and a leading
cause of chronic liver disease. 5 An estimated 180 million people are infected worldwide. 6 …

Background: The need for new non‐invasive tools to assess liver fibrosis in chronic liver
diseases has been largely advocated. Liver stiffness measurement (LSM) using transient …

The aim of this study is to know the liver stiffness measurement (LSM) cutoffs for different
stages of liver fibrosis in chronic hepatitis B (CHB) and to investigate the effect of alanine …

Background and aims: The current study aims to evaluate the performance of a new
elastographic method (ARFI) in noninvasive fibrosis assessment and to compare it to …

Histopathological scoring of disease stage uses descriptive categories without measuring
the amount of fibrosis. Collagen, the major component of fibrous tissue, can be quantified by …

Background and aims: Transient elastography is increasingly being used in patients with
chronic liver disease. It has proven particularly useful to identify patients with advanced …

Background: Metabolic syndrome is associated with non-alcoholic steatohepatitis and
cryptogenic cirrhosis. Whether metabolic syndrome affects the severity of chronic hepatitis B …

The purpose of this study was to assess the influence of success rate and interquartile range
on the accuracy of transient elastography for the diagnostic of fibrosis in hepatitis C virus …

Liver biopsy is considered the “golden standard” for assessment of hepatic fibrosis.
However, the procedure has limitations because of inconvenience and rare but serious …